LDN-071, A NOVEL FIRST-IN-CLASS PEPTIDE-BASED PLASMINOGEN ACTIVATOR INHIBITOR 1, SIGNIFICANTLY REDUCES THE SEVERITY OF EXPERIMENTAL COLITIS IN MICE

Boldizsár Jójárt  1     Noémi Csákány-Papp  2, 3, 4     Hajnalka Laub  1, 2     Béla Vasas  2     Bence Barta  5     Viktória Szabó  2, 3, 4     Mária Bagyánszki  5     István Mándity  1, 6     Gábor Heltovics  1     Petra Pallagi  1, 2, 3, 7     József Maléth  1, 2, 3, 7    
1 Ladon Therapeutics Ltd, Szeged, Hungary
2 University of Szeged, Szent-Györgyi Albert Medical School, Szeged, Hungary
3 ELKH-USz Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary
4 HCEMM-USz Molecular Gastroenterology Research Group, Szeged, Hungary
5 University of Szeged, Faculty of Science and Informatics, Szeged, Hungary
6 Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, Budapest, Hungary
7 HCEMM-USz Molecular Gastroenterology Re

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing